Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Quantitative Analysis of Tumor-Specific BCL2 Expression in DLBCL: Refinement of Prognostic Relevance of BCL2

Jin Roh, Hyungwoo Cho, MD, Dok Hyun Yoon, Jung Yong Hong, A-Neum Lee, Hyeon-Seok Eom, Hyewon Lee, MD, Weon Seo Park, Jae Ho Han, MD, Seong Hyun Jeong, Joon Seong Park, MD, Hyo-Kyung Pak, So-Woon Kim, MD, Sang-Yeob Kim, Cheolwon Suh, Jooryung Huh, Chan-Sik Park

Blood (2019) 134 (Supplement_1): 2901.

https://doi.org/10.1182/blood-2019-130279

Published: 2019

Journal Articles

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Hyehyun Jeong, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan Sik Park, MD, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5346.

https://doi.org/10.1182/blood-2018-99-119980

Published: 2018

Journal Articles

Prognostic Value of Serum Beta-2 Microglobulin during and after Completing Chemotherapy in Marginal Zone Lymphoma

Byung Woo Yoon, Jung Yong Hong, Dok Hyun Yoon, Kyoung Min Lee, Shin Kim, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Chan-jeoung Park, Seongsoo Jang, Jin-Sook Ryu, Sang Wook Lee, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5335.

https://doi.org/10.1182/blood-2018-99-115781

Published: 2018

Journal Articles

Serum Beta-2 Microglobulin Predicts the Survival Outcome after Autologous Stem Cell Transplantation in Relapse or Refractory Diffuse Large B Cell Lymphoma

Hyeun-Su Im, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan-Sik Park, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5755.

https://doi.org/10.1182/blood-2018-99-120334

Published: 2018

Journal Articles

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5762.

https://doi.org/10.1182/blood-2018-99-118222

Published: 2018

Journal Articles

Prophylaxis of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Single Center Experience

Joo Young Ha, MD, Kyoungmin Lee, MD, Jung Yong Hong, Dok Hyun Yoon, Sung-Han Kim, Seongsoo Jang, Chan-Sik Park, Jooryung Huh, Jin-Sook Ryu, Sang-wook Lee, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5832.

https://doi.org/10.1182/blood-2018-99-118360

Published: 2018

Journal Articles

Central Nervous System Relapse in Patients with Extranodal NK/T-Cell Lymphoma, Nasal Type

Hyehyun Jeong, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan Sik Park, MD, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 1634.

https://doi.org/10.1182/blood-2018-99-120137

Published: 2018

Journal Articles

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 2995.

https://doi.org/10.1182/blood-2018-99-118221

Published: 2018

Journal Articles

Low Relapse Rate after 2 Years in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP and Achieved Complete Response

Junho Kang, MD, Kyoungmin Lee, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan-Sik Park, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 2996.

https://doi.org/10.1182/blood-2018-99-119922

Published: 2018

Journal Articles

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4139.

https://doi.org/10.1182/blood.V130.Suppl_1.4139.4139

Published: 2017

Journal Articles

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Min Young Lee, MD PhD, Chan-jeoung Park, MD, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, MD, Jung-Hee Lee, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4400.

https://doi.org/10.1182/blood.V130.Suppl_1.4400.4400

Published: 2017

Journal Articles

A Phase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma

Silvia Park, Seok Jin Kim, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Jin Seok Kim, MD PhD, Hye Jin Kang, MD PhD, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, MD PhD, Won Seog Kim, MD, Ph. D.

Blood (2017) 130 (Supplement 1): 4077.

https://doi.org/10.1182/blood.V130.Suppl_1.4077.4077

Published: 2017

Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blood (2017) 130 (Supplement 1): 2840.

https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840

Published: 2017

Journal Articles

Difference of Clinical Parameters between GCB and Non-GCB Subtype DLBCL

Moonho Kim, MD, Cheolwon Suh, MD PhD, Jaejoon KIM, Jung Yong Hong

Blood (2017) 130 (Supplement 1): 5231.

https://doi.org/10.1182/blood.V130.Suppl_1.5231.5231

Published: 2017

Journal Articles

Difference of Clinical Parameters between Limited and Advanced Stage DLBCL

Moonho Kim, Cheolwon Suh, MD PhD, Jaejoon KIM, Jung Yong Hong

Blood (2017) 130 (Supplement 1): 5238.

https://doi.org/10.1182/blood.V130.Suppl_1.5238.5238

Published: 2017

Journal Articles

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Sung Yong Oh, Jin Seok Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Seog Kim, MD, Ph. D., Seok Jin Kim, MD PhD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Won-Sik Lee, MD, Hyo Jung Kim, MD PhD, Jong-Ho Won, MD, Byeong Park, MD, Soon Il Lee, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5155.

https://doi.org/10.1182/blood.V130.Suppl_1.5155.5155

Published: 2017

Journal Articles

CD34+ Cell Count and Disease Free Survival in Patients with Diffuse Large B Cell Lymphoma Who Have Received Autologous Stem Cell Transplantaion

Jaejoon KIM, Cheolwon Suh, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Moonho Kim

Blood (2017) 130 (Supplement 1): 5519.

https://doi.org/10.1182/blood.V130.Suppl_1.5519.5519

Published: 2017

Journal Articles

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Kyoungmin Lee, MD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Jung Bok Lee, PhD, Shin Kim, RN, Jung Sun Park, MSc, Jooryung Huh, MD PhD, Sang Wook Lee, MD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4130.

https://doi.org/10.1182/blood.V130.Suppl_1.4130.4130

Published: 2017

Journal Articles

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Blood (2017) 130 (Supplement 1): 4088.

https://doi.org/10.1182/blood.V130.Suppl_1.4088.4088

Published: 2017

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

NARROW

Quantitative Analysis of Tumor-Specific BCL2 Expression in DLBCL: Refinement of Prognostic Relevance of BCL2

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Prognostic Value of Serum Beta-2 Microglobulin during and after Completing Chemotherapy in Marginal Zone Lymphoma

Serum Beta-2 Microglobulin Predicts the Survival Outcome after Autologous Stem Cell Transplantation in Relapse or Refractory Diffuse Large B Cell Lymphoma

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Prophylaxis of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Single Center Experience

Central Nervous System Relapse in Patients with Extranodal NK/T-Cell Lymphoma, Nasal Type

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

Low Relapse Rate after 2 Years in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP and Achieved Complete Response

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

A Phase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Difference of Clinical Parameters between GCB and Non-GCB Subtype DLBCL

Difference of Clinical Parameters between Limited and Advanced Stage DLBCL

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

CD34+ Cell Count and Disease Free Survival in Patients with Diffuse Large B Cell Lymphoma Who Have Received Autologous Stem Cell Transplantaion

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only